P63, P13K and RAS oncogenes in tumorigenesis, immune deregulation and therapy of squamous cell carcinoma
|
Research Initiative
|
FDA
|
NIDCD
|
2014
|
|
Pathogen Detection Project and Interagency Collaboration on Genomics for Food and Feed Safety (Gen-FS)
|
Resource Development
|
CDC, FDA
|
|
2015
|
|
PCC Technical Working Group on PFAS
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ATSDR
|
|
|
|
Pediatric COVID-19/MIS-C Interagency Team
|
Committee, Advisory Group, or Work Group
|
FDA, CDC, ASPR
|
NICHD, NHLBI, NIAID
|
|
|
Pediatric COVID-19/Multisystem Inflammatory Syndrome in Children (MIS-C) interagency team
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NHLBI, NICHD
|
2020
|
|
Pilot Biosurveillance Working Group - National Biodefense Strategy
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ASPR
|
NIAID
|
2021
|
|
Policies and Regulatory Pathways to FDA Licensure
|
Meeting/ Workshop
|
FDA
|
NIAID
|
2018
|
|
Population Assessment of Tobacco and Health (PATH) Study
|
Health Survey
|
FDA
|
NIDA
|
2011
|
|
Post Market Safety Study of Opoids
|
Research Initiative
|
FDA
|
NIDA
|
2014
|
|
Postdoctoral Fellowship in Genomic Science and Health Equity
|
Training Initiative
|
FDA
|
|
2021
|
|
Preclinical Assessment of Phage Therapy for Pathogen Decolonization
|
Research Initiative
|
FDA
|
NIAID
|
2015
|
|
Predictive Biodosimetry Guidance Planning Working Group
|
Committee, Advisory Group, or Work Group
|
ASPR, FDA
|
NIAID
|
2020
|
|
Pregnancy and Birth to 24 Months (P/B-24) Project
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, OS
|
NCI, NHLBI, NICHD, NIDDK
|
2012
|
|
President's Task Force on Environmental Health Risks and Safety Risks to Children (PTFCEH)
|
Committee, Advisory Group, or Work Group
|
ACF, ASPR, CDC, ATSDR, FDA, OASH, SAMHSA
|
NICHD, NHLBI, NIMH, NIMHD
|
|
|
President's Task Force on Environmental Health Risks and Safety Risks to Children: Lead Exposures Subcommittee
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, HRSA, OS
|
NHLBI, NICHD, NIEHS, OD/ DPCPSI/ ODP
|
|
|
Prevention Research Coordinating Committee (PRCC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, OS, FDA, OASH
|
CC, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI/ OAR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ORWH, OD/ DPCPSI/ ODS, OD/ OLPA
|
1997
|
|
Probiotic and Prebiotic Working Group [PPWG] (PPWG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCCIH, NCI, NIAMS, NIDA, NIDCR, OD/ DPCPSI/ ODS, CC, CIT, CSR, FIC, NCATS, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIBIB, NICHD, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OEDI
|
2006
|
|
Promoting Semantic Interoperability of Laboratory Data Test Results
|
Resource Development
|
CDC, FDA
|
|
2015
|
|
Public Health and Emergency Medical Countermeasures Enterprise (PHEMCE)
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, OS, SAMHSA
|
NIAID, NIAMS, NICHD, NINDS, NLM
|
2007
|
|
Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Preparedness Against Chemical Threats (PACT) Working Group (PHEMCE PACT Working Group)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, NINDS
|
2007
|
|
Public Health Service Technology Transfer Policy Board (TTPB)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
|
1994
|
|
|